Formulations for delivery of therapeutic proteins
暂无分享,去创建一个
[1] L. Illum. Is nose‐to‐brain transport of drugs in man a reality? , 2004, The Journal of pharmacy and pharmacology.
[2] A. Margolin,et al. Novel Long-Acting Crystal Formulation of Human Growth Hormone , 2005, Pharmaceutical Research.
[3] Y. Kawashima,et al. Mucoadhesive nanoparticulate systems for peptide drug delivery. , 2001, Advanced drug delivery reviews.
[4] K. Read,et al. Evaluation of Direct Transport Pathways of Glycine Receptor Antagonists and an Angiotensin Antagonist from the Nasal Cavity to the Central Nervous System in the Rat Model , 2008, Pharmaceutical Research.
[5] Steven F Dowdy,et al. Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer. , 2005, Advanced drug delivery reviews.
[6] L. Bromberg,et al. Insulin particle formation in supersaturated aqueous solutions of poly(ethylene glycol). , 2005, Biophysical journal.
[7] M. Wagh,et al. Thiomers: A New Generation of Mucoadhesive Polymers , 2009 .
[8] A. Margolin,et al. Protein crystals for the delivery of biopharmaceuticals , 2004, Expert opinion on biological therapy.
[9] William V Giannobile,et al. The enhancement of osteogenesis by nano-fibrous scaffolds incorporating rhBMP-7 nanospheres. , 2007, Biomaterials.
[10] Y. Nam,et al. Intracellular drug delivery using poly(d,l-lactide-co-glycolide) nano- particles derivatized with a peptide from a transcriptional activator protein of HIV-1 , 2002, Biotechnology Letters.
[11] R. Bodmeier,et al. A novel in situ forming drug delivery system for controlled parenteral drug delivery. , 2007, International journal of pharmaceutics.
[12] W. Rubas,et al. Flux measurements across Caco-2 monolayers may predict transport in human large intestinal tissue. , 1996, Journal of pharmaceutical sciences.
[13] A. Roșeanu,et al. Designing Lipid Nanostructures for Local Delivery of Biologically Active Macromolecules , 2007, Journal of liposome research.
[14] A. Boer,et al. Strategies to Improve Drug Delivery Across the Blood-Brain Barrier , 2007, Clinical pharmacokinetics.
[15] A. Bernkop‐Schnürch,et al. Thiolated chitosan microparticles: a vehicle for nasal peptide drug delivery. , 2006, International journal of pharmaceutics.
[16] Deepak Chitkara,et al. Biodegradable injectable in situ depot-forming drug delivery systems. , 2006, Macromolecular bioscience.
[17] Daniel Howard,et al. Zonal release of proteins within tissue engineering scaffolds , 2006, Journal of materials science. Materials in medicine.
[18] Ashutosh Chilkoti,et al. A thermally responsive biopolymer for intra-articular drug delivery. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[19] D. Fischer,et al. Uptake and Transport of PEG-Graft-Trimethyl-Chitosan Copolymer–Insulin Nanocomplexes by Epithelial Cells , 2005, Pharmaceutical Research.
[20] Wim E Hennink,et al. Biodegradable dextran hydrogels for protein delivery applications , 2007, Expert review of medical devices.
[21] S. Stolnik,et al. Macroporous surface modified microparticles. , 2008, Soft matter.
[22] K. Yagi,et al. A novel strategy for a drug delivery system using a claudin modulator. , 2006, Biological & pharmaceutical bulletin.
[23] David J Mooney,et al. Integrated approach to designing growth factor delivery systems , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[24] E. Schwiebert,et al. Effects of the permeability enhancers, tetradecylmaltoside and dimethyl-beta-cyclodextrin, on insulin movement across human bronchial epithelial cells (16HBE14o-). , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[25] D. Pritchard,et al. The assessment of hookworm calreticulin as a potential vaccine for necatoriasis , 2005, Parasite immunology.
[26] J. Robinson,et al. Bioadhesive-based dosage forms: the next generation. , 2000, Journal of pharmaceutical sciences.
[27] H. Natsume,et al. Effect of poly-L-arginine on the nasal absorption of FITC-dextran of different molecular weights and recombinant human granulocyte colony-stimulating factor (rhG-CSF) in rats. , 2001, International journal of pharmaceutics.
[28] Janos Szebeni,et al. Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity. , 2005, Toxicology.
[29] E. A. Pearson,et al. Surface modification of microspheres with steric stabilizing and cationic polymers for gene delivery. , 2008, Langmuir : the ACS journal of surfaces and colloids.
[30] S. Quay,et al. Therapeutic utility of a novel tight junction modulating peptide for enhancing intranasal drug delivery. , 2006, Journal of pharmaceutical sciences.
[31] Z. Qian,et al. Transferrin/transferrin receptor-mediated drug delivery. , 2002, Medicinal research reviews.
[32] D. Dalkara,et al. Intracytoplasmic delivery of anionic proteins. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.
[33] N. Peppas,et al. Complexation hydrogels for oral insulin delivery: effects of polymer dosing on in vivo efficacy. , 2008, Journal of pharmaceutical sciences.
[34] T. Park,et al. Temperature-responsive and degradable hyaluronic acid/Pluronic composite hydrogels for controlled release of human growth hormone. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[35] D. Jans,et al. Protein transduction: cell penetrating peptides and their therapeutic applications. , 2006, Current medicinal chemistry.
[36] Chan‐Wha Kim,et al. Insulin microcrystal suspension as a long-acting formulation for pulmonary delivery. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[37] J Woodley,et al. Bioadhesion: new possibilities for drug administration? , 2001, Clinical pharmacokinetics.
[38] B. Sarmento,et al. Lipid-based colloidal carriers for peptide and protein delivery – liposomes versus lipid nanoparticles , 2007, International journal of nanomedicine.
[39] Fakhrul Ahsan,et al. Absorption enhancers in pulmonary protein delivery. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[40] N. Peppas,et al. Stimuli-sensitive protein delivery systems , 2006 .
[41] E. Horjales,et al. Cross-linked crystals of chloroperoxidase. , 2002, Biochemical and biophysical research communications.
[42] Laura Indolfi,et al. Microsphere-integrated collagen scaffolds for tissue engineering: effect of microsphere formulation and scaffold properties on protein release kinetics. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[43] N. Peppas,et al. Is the oral route possible for peptide and protein drug delivery? , 2006, Drug discovery today.
[44] A. Jaklenec,et al. Novel scaffolds fabricated from protein-loaded microspheres for tissue engineering. , 2008, Biomaterials.
[45] S. Chan,et al. Efficient intracellular delivery of functional proteins using cationic polymer core/shell nanoparticles. , 2008, Biomaterials.
[46] Xinguo Jiang,et al. Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[47] Yan Jin,et al. Periodontal regeneration using novel glycidyl methacrylated dextran (Dex-GMA)/gelatin scaffolds containing microspheres loaded with bone morphogenetic proteins. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[48] A. Metters,et al. Hydrogels in controlled release formulations: network design and mathematical modeling. , 2006, Advanced drug delivery reviews.
[49] P. Caliceti,et al. Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates. , 2003, Advanced drug delivery reviews.
[50] B. Hirst,et al. M cell targeting by lectins: a strategy for mucosal vaccination and drug delivery. , 2004, Advanced drug delivery reviews.
[51] K. Chung,et al. Molecular mechanisms of pulmonary peptidomimetic drug and peptide transport. , 2004, American journal of respiratory cell and molecular biology.
[52] H. Junginger,et al. Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[53] C. Highley,et al. Anti-inflammatory function of an in situ cross-linkable conjugate hydrogel of hyaluronic acid and dexamethasone. , 2007, Biomaterials.
[54] A. Vila,et al. Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[55] W. Pardridge,et al. GDNF fusion protein for targeted‐drug delivery across the human blood–brain barrier , 2008, Biotechnology and bioengineering.
[56] Lisbeth Illum,et al. Long circulating microparticulate drug carriers , 1995 .
[57] L. Brown. Commercial challenges of protein drug delivery , 2005, Expert opinion on drug delivery.
[58] T Morçöl,et al. Calcium phosphate-PEG-insulin-casein (CAPIC) particles as oral delivery systems for insulin. , 2004, International journal of pharmaceutics.
[59] W. Pardridge. Blood-brain barrier delivery of protein and non-viral gene therapeutics with molecular Trojan horses. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[60] N. Katre. Liposome-based depot injection technologies , 2004 .
[61] H. Merkle,et al. Diamonds in the rough: protein crystals from a formulation perspective. , 2001 .
[62] A. Metters,et al. Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: Engineering cell-invasion characteristics , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[63] E. Vivés,et al. Tat peptide-mediated cellular delivery: back to basics. , 2005, Advanced drug delivery reviews.
[64] A. Bernkop‐Schnürch,et al. Nasal delivery of human growth hormone: in vitro and in vivo evaluation of a thiomer/glutathione microparticulate delivery system. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[65] F. Szoka,et al. HIV TAT Protein Transduction Domain Mediated Cell Binding and Intracellular Delivery of Nanoparticles. , 2003, Journal of dispersion science and technology.
[66] A. Hubbard,et al. Transcytosis: crossing cellular barriers. , 2003, Physiological reviews.
[67] C. Lehr,et al. Lectins and bacterial invasion factors for controlling endo- and transcytosis of bioadhesive drug carrier systems☆ , 1997 .
[68] A. Hoffman,et al. Smart polymeric carriers for enhanced intracellular delivery of therapeutic macromolecules , 2005, Expert opinion on biological therapy.
[69] Na Zhang,et al. PLGA nanoparticle--peptide conjugate effectively targets intercellular cell-adhesion molecule-1. , 2008, Bioconjugate chemistry.
[70] K. Shakesheff,et al. The production of protein-loaded microparticles by supercritical fluid enhanced mixing and spraying. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[71] I. Verma,et al. Targeted delivery of proteins across the blood–brain barrier , 2007, Proceedings of the National Academy of Sciences.
[72] J. Tessmar,et al. Matrices and scaffolds for protein delivery in tissue engineering. , 2007, Advanced drug delivery reviews.